Home > Insider Trading > Filing (0001209191-14-060549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157602	Vitae Pharmaceuticals Inc	VTAE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291895	Peter Barrett	C/O Atlas Venture 25 First Street, Suite 303 Cambridge MA 02141		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-29	1,099,743	$0.00	1,099,743	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	37,072	$0.00	1,136,815	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	37,500	$8.00	1,174,315	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2014-09-29	1,099,743	$0.00	1,099,743	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-09-29	37,072	$0.00	37,072	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The reportable securities include 1,048,482 shares owned by Atlas Venture Fund VI, L.P. ("Atlas VI"), 32,063 shares owned by Atlas Venture Entrepreneurs' Fund VI, L.P. ("Atlas EVC") and 19,198 shares owned by Atlas Venture Fund VI GmbH & Co. KG ("Atlas GmbH").
Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted on a 1:1 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
Dr. Barrett is a partner of Atlas Venture, and as such Dr. Barrett may be deemed to share voting and dispositive power with respect to all shares held by such entity. Dr. Barrett disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The reportable securities include 35,345 shares owned by Atlas VI, 1,080 shares owned by Atlas EVC and 647 shares owned by Atlas GmbH.
The reportable securities include 1,083,827 shares owned by Atlas VI, 33,143 shares owned by Atlas EVC and 19,845 shares owned by Atlas GmbH.
The reportable securities include 35,753 shares owned by Atlas VI, 1,093 shares owned by Atlas EVC and 654 shares owned by Atlas GmbH.
The reportable securities include 1,119,580 shares owned by Atlas VI, 34,236 shares owned by Atlas EVC and 20,499 shares owned by Atlas GmbH.